Program Book
Total Page:16
File Type:pdf, Size:1020Kb
Program Book Page 1 Visit BD at Booth 105 BD MAX™ Vaginal Panel One clinician- or patient-collected vaginal swab provides results for the three most common causes of vaginitis – bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and Trichomonas vaginalis (TV)1. BD MAX Vaginal Panel detects DNA from In addition, BD MAX Vaginal Panel utilizes the the following BV markers: CDC-recommended diagnostic technology for T. vaginalis detection2 and provides three results for microorganisms responsible for Lactobacillus spp. yeast infections: G. vaginalis • group, including C. albicans, C. A. vaginae Candida L. jensenii parapsilosis, C. tropicalis, and C. dubliniensis L. crispatus BVAB-2 Megasphaera-1 • Differentiates fungal species – C. glabrata Anaerobic spp. and C. krusei – associated with antimicrobial resistance3. The BD MAX™ Women’s Health and STI portfolio is focused on providing accurate, reliable results that enable clinicians and labs to elevate patient care. • BD MAX™ Vaginal Panel • BD MAX™ CT/GC/TV • BD MAX™ GBS Reference 1. BD MAX Vaginal Panel Package Insert 2. CDC (2015, June). MMWR Sexually Transmitted Diseases Treatment Guidelines, 2015. Mills, BB (2017) Vaginitis: Beyond the Basics. Obstet Gynecol Clin North Am. 44(2):159-177. 3. Gaydos CA (2017) Clinical Validation of a Test for the Diagnosis of Vaginitis. Obstet Gynecol. 130(1):181-189. BD, the BD Logo and the BD MAX are trademarks of Becton, Dickinson and Company or its affiliates. © 2019 BD. All rights reserved. April 2019. Page 2 MAX MVP AD_5_5x8_5_GreenJournalAd_April.indd 1 4/24/19 2:44 PM STI & HIV 2019 SUPPORTERS STI & HIV 2019 would like to thank the following companies for their generous support: SPONSORS PLATINUM LEVEL GOLD LEVEL SILVER LEVEL BRONZE LEVEL OTHER SUPPORTERS Page 3 TABLE OF CONTENTS Page 5 WELCOME ADDRESS Page 6 COMMITTEES Page 11 ABOUT Page 12 ISSTDR Board Listing Page 13 IUSTI EXecutive Committee Listing Page 15 KEYNOTE, PLENARY & DEBATE SPEAKERS Page 23 SCHOLARSHIPS Page 24 ABSTRACT REVIEWERS Page 26 PROGRAM AT A GLANCE Page 29 SCIENTIFIC PROGRAM • Sunday, July 14 • Monday, July 15 • Tuesday, July 16 • Wednesday, July 17 • Posters Page 80 Industry-Supported Symposia Page 82 BOARD & SIDE MEETINGS Page 84 NETWORKING EVENTS Page 85 GENERAL INFORMATION Page 89 VENUE FLOOR PLAN Page 90 EXhibit Floor Plan Page 92 EXhibitor Biographies Page 4 WELCOME ADDRESS Dear Friends and Colleagues, On behalf of the Organizing Committee, we are delighted you have decided to attend the STI & HIV 2019 World Congress to be held July 14 – 17, 2019, at the Vancouver Convention Centre East Building, in Vancouver, British Columbia, Canada. This Congress is a joint meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR) and the International Union Against Sexually Transmitted Infections (IUSTI). This biennial meeting is the world’s largest international meeting on sexually transmitted infections, drawing delegates from around the globe. Under the theme of ‘The Evolving Landscape of STI and HIV Elimination’, this meeting will provide an excellent opportunity for the world’s most prominent researchers and health professionals to come together in the shared goal of improving global public health in the field of sexually transmitted infections, including HIV. The meeting will provide Congress attendees the opportunity to network with experts, present their research findings to an international audience, hear the latest scientific developments from world leaders in the STI/HIV field, and contribute to discussions that will shape future health policies and patient care around the world. The STI & HIV 2019 World Congress is taking place in one of the most stunning cities in the world. Vancouver is a safe, modern, multicultural city with a vibrant local arts and culture scene and abundant opportunities for outdoor adventures amongst a setting of incomparable natural beauty. We welcome you to Vancouver and look forward to providing you with an exceptional scientific and cultural experience! Warm regards, Caroline Cameron, Chair Charlotte Gaydos, Co-Chair International Society for International Union Against Sexually Transmitted Sexually Transmitted Diseases Research, President Infections, President University of Victoria, Canada Johns Hopkins University, USA A Message from the Mayor On behalf of my colleagues on Vancouver City Council and the citizens of Vancouver I want to extend my warmest greetings to the delegates of the International Society for Sexually Transmitted Diseases Research (ISSTDR) and the International Union Against Sexually Transmitted Infections (IUSTI) who are co-hosting the STI & HIV 2019 World Congress. The opportunity to share research and scientific developments is crucial to developing policies and platforms that enhance the well-being of all citizens. With the goal of improving global public health in the field of sexually transmitted infections including HIV/AIDS, ISSTDR and IUSTI help shape discussions around future health policies and patient care around the world. We are proud to host the STI & HIV 2019 World Congress in Vancouver and I hope that in addition to attending the conference you are able to experience the many cultural and recreational activities the City has to offer. I know everyone involved in organizing the conference will ensure your time with us is special. Best wishes on a successful and productive conference. Mayor Kennedy Stewart Page 5 COMMITTEES Scientific Committee Co-Chairpersons David Lewis Western Sydney Sexual Health Centre, Western Sydney Local Health District, Parramatta, Australia; Westmead Clinical School, University of Sydney, Sydney, Australia; Division of Medical Virology, University of Cape Town, Cape Town, South Africa James Blanchard Departments of Community Health Sciences and Medical Microbiology, Centre for Global Public Health, Canada Research Chair in Epidemiology and Global Public Health, Faculty of Medicine University of Manitoba Basic & Translational Science Track Team Chairperson: Track Members: Jo-Anne Dillon Will Geisler Canada USA Sheila Lukehart University of Laura Sycuro Nick Thomson Washington, USA Canada UK Magnus Unemo Anna Wald Sweden USA David Whiley Australia Behavioural & Social Sciences Track Team Chairperson: Track Members: Jacky Jennings Valeria Stuardo Avila Sarah Bernays Johns Hopkins School Chile Australia of Medicine, Bloomberg School of Public Health, Kit Fairley Robert Lorway Center for Child and Australia Canada Community Health Research, USA Joe Tucker USA Page 6 COMMITTEES Clinical Science Track Team Chairperson: Track Members: Matthew Golden Catriona Bradshaw Craig Cohen University of Australia USA Washington (UW) School of Medicine, Julie Dombrowski Gina Ogilvie Seattle & King County USA Canada HIV/STD Program, UW Public Health Daniel Richardson Janet Wilson Capacity Building Australia UK Center, USA Ping Yu Zhou China Epidemiology & Monitoring Track Team Chairperson: Track Members: Gwenda Hughes Michel Alary Kyle Bernstein National Infection Canada USA Service at Public Health England, Viviane Bremer Xiang-Sheng Chen Gonococcal Germany China Resistance to Antimicrobials Sinead Delaney- Maria Amelia de Surveillance Moretlwe Sousa Mascena Programme South Africa Veras (GRASP), UK Brazil Jane Hocking Australia Policy & Community Engagement Track Team Chairperson: Track Members: Patricia Garcia Francis Ndowa Helen Ward Peru Zimbabwe Imperial College London, UK Maryam Kate Shannon Shahmanesh Canada UK Morten Skovdal Denmark Page 7 COMMITTEES Program & Implementation Science Track Team Chairperson: Track Members: Sevgi Aral Marissa Becker Parinita Bhattacharjee US Centers for Canada Kenya/Canada Disease Control, University of Harrell Chesson James Hargreaves Washington, USA UK Emory University, Sharmistha Mishra USA, University of Ian Spicknall Canada Manitoba, Canada USA Anneli Uusküla Estonia Local Organizing Committee Chair: Co-Chair: Caroline Cameron Charlotte Gaydos University of Victoria, Canada Johns Hopkins University, USA Lindsay Frehlick Mark Gilbert Troy Grennan King Holmes University of University of British University of British University of Victoria, Canada Columbia, British Columbia, British Washington, USA Columbia Centre for Columbia Centre for Disease Control, Canada Disease Control, Canada Rupert Kaul Mel Krajden Nathan Lachowsky Sheila Lukehart University of University of British University of University of Toronto, Canada Columbia, British Victoria, Canada Washington, USA Columbia Centre for Disease Control, Canada Muhammed Morshed Lisa Manhart Jeanne Marrazzo Deborah Money University of British University of University of University of British Columbia, British Washington, USA Alabama, USA Columbia, Canada Columbia Centre for Disease Control, Canada Gina Ogilvie Michael Rekart Ameeta Singh Mark Tyndall University of British University of British University of University of British Columbia, British Columbia, British Columbia, British Alberta, Canada Columbia Centre for Columbia Centre for Columbia Centre for Disease Control, Canada Disease Control, Canada Disease Control, Canada Jason Wong University of British Columbia, British Columbia Centre for Disease Control, Canada Page 8 COMMITTEES nə́ c̓ aʔmat ct Indigenous Sexual Health Committee The purpose of this committee is to raise the prominence of Indigenous sexual health within the conference and to work with the Local Organizing Committee to establish relations in a good way with the local Coast Salish peoples on whose traditional, ancestral and unceded territories